Results 191 to 200 of about 711,468 (219)

Reply to the Letter by Mazzitelli M. et al. Regarding “Impact of COVID‐19 on Hematologic Cancer Patients: Insights From the Late Pandemic Phase”

open access: yes
Cancer Medicine, Volume 15, Issue 10, October 2026.
Daniele Caracciolo   +2 more
wiley   +1 more source

Correction to: The role of passive immunization in the age of SARS-CoV-2: an update. [PDF]

open access: yesEur J Med Res, 2020
Fischer JC   +19 more
europepmc   +1 more source

Development of IgY-Based Passive Immunization Against Tilapia Lake Virus: Development and In Vitro Neutralization Assays. [PDF]

open access: yesViruses
Setthawong P   +8 more
europepmc   +1 more source

State Immunization Investments : Alabama

open access: yes
Alabama$70,568,729Vaccines for Children Program (VFC)Vaccines: $64,494,573Program Operations: $1,090,320Other Funding: $4,983,836Publication date from document properties.Alabama-2019-CDC-Immunization-Investments ...

core   +1 more source

Immunization Investments by Location : Immunization Investment

open access: yes
Vaccines are one of the most effective tools to protect the public\u2019s health and prevent disease. In the United States today, we enjoy record-high immunization coverage rates for most childhood vaccines and increasing coverage rates for adolescent ...

core  

State Immunization Investments : Palau

open access: yes
Palau$441,986Immunization Program Award Funding:$351,468Other Funding: $90,518Publication date from document properties.Palau-2019-CDC-Immunization-Investments ...

core  

State Immunization Investments : Texas

open access: yes
Texas$513,556,666Vaccines for Children Program (VFC)Vaccines: $474,966,830Program Operations: $7,198,688Other Funding: $31,391,147Publication date from document properties.Texas-2019-CDC-Immunization-Investments ...

core  

Potent neutralizing equine antibodies raised against recombinant SARS-CoV-2 spike protein for COVID-19 passive immunization therapy

open access: yes, 2020
Cunha LER   +26 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy